• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年髋部骨折患者血清C端集聚蛋白片段(CAF)水平与肌肉减少症相关。

Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients.

作者信息

Marzetti Emanuele, Calvani Riccardo, Lorenzi Maria, Marini Federico, D'Angelo Emanuela, Martone Anna Maria, Celi Michela, Tosato Matteo, Bernabei Roberto, Landi Francesco

机构信息

Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart, Rome, Italy.

Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Exp Gerontol. 2014 Dec;60:79-82. doi: 10.1016/j.exger.2014.10.003. Epub 2014 Oct 7.

DOI:10.1016/j.exger.2014.10.003
PMID:25304331
Abstract

BACKGROUND

Serum concentrations of the C-terminal fragment of agrin (CAF), a component of the neuromuscular junction (NMJ), are elevated in older community-dwellers with sarcopenia. Whether CAF may be used as a marker for muscle wasting in the presence of NMJ mechanical damage is presently unknown. The present study was undertaken to verify if serum CAF levels were associated with sarcopenia in older hip fractured patients.

METHODS

Analyses were conducted in older adults hospitalized for traumatic hip fracture. The presence of sarcopenia was established according to the European Working Group on Sarcopenia in Older People criteria, with bioelectrical impedance analysis used for muscle mass estimation. Serum levels of CAF were determined using a commercial ELISA kit.

RESULTS

Among 42 hip fractured patients (age 83.7±8.6 years, 76.2% women), sarcopenia was diagnosed in 7 individuals (16.7%). Serum CAF levels were significantly higher in sarcopenic relative to non-sarcopenic patients (172.2±47.5 pM vs. 93.1±44.0 pM; p<0.001). The association remained significant in both genders after adjustment for several potential confounders.

CONCLUSION

Elevated serum CAF concentrations are associated with sarcopenia in older adults with hip fracture. The determination of serum CAF levels could therefore serve to identify a subset of hip fractured patients at especially high risk for adverse health outcomes.

摘要

背景

在患有肌肉减少症的老年社区居民中,神经肌肉接头(NMJ)的一种成分——聚集蛋白C端片段(CAF)的血清浓度会升高。目前尚不清楚在存在NMJ机械损伤的情况下,CAF是否可作为肌肉萎缩的标志物。本研究旨在验证血清CAF水平是否与老年髋部骨折患者的肌肉减少症相关。

方法

对因创伤性髋部骨折住院的老年人进行分析。根据欧洲老年人肌肉减少症工作组的标准确定是否存在肌肉减少症,使用生物电阻抗分析来估计肌肉质量。使用商用ELISA试剂盒测定血清CAF水平。

结果

在42例髋部骨折患者(年龄83.7±8.6岁,76.2%为女性)中,7例(16.7%)被诊断为肌肉减少症。与非肌肉减少症患者相比,肌肉减少症患者的血清CAF水平显著更高(172.2±47.5 pM对93.1±44.0 pM;p<0.001)。在调整了几个潜在混杂因素后,该关联在两性中均仍然显著。

结论

血清CAF浓度升高与老年髋部骨折患者的肌肉减少症相关。因此,测定血清CAF水平可用于识别一部分髋部骨折患者,这些患者出现不良健康结局的风险特别高。

相似文献

1
Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients.老年髋部骨折患者血清C端集聚蛋白片段(CAF)水平与肌肉减少症相关。
Exp Gerontol. 2014 Dec;60:79-82. doi: 10.1016/j.exger.2014.10.003. Epub 2014 Oct 7.
2
Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older multimorbid community-dwellers: Results from the ilSIRENTE study.血清C端集聚蛋白片段(CAF)水平与多病共存的老年社区居民肌肉减少症相关:来自ilSIRENTE研究的结果。
Exp Gerontol. 2016 Jun 15;79:31-6. doi: 10.1016/j.exger.2016.03.012. Epub 2016 Mar 23.
3
C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction.C 端聚集蛋白片段作为神经肌肉接头退变导致的肌肉减少症的潜在标志物。
Exp Gerontol. 2013 Jan;48(1):76-80. doi: 10.1016/j.exger.2012.05.021. Epub 2012 Jun 7.
4
Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.升高的 C 端神经胶质细胞衍生神经营养因子片段水平可识别出一类新的骨骼肌减少症患者亚群。
Exp Gerontol. 2013 Jan;48(1):69-75. doi: 10.1016/j.exger.2012.03.002. Epub 2012 Mar 11.
5
Plasma C-Terminal Agrin Fragment as an Early Biomarker for Sarcopenia: Results From the GenoFit Study.血浆 C 端神经黏附蛋白片段作为肌少症的早期生物标志物:GenoFit 研究结果。
J Gerontol A Biol Sci Med Sci. 2021 Nov 15;76(12):2090-2096. doi: 10.1093/gerona/glab139.
6
Testosterone does not affect agrin cleavage in mobility-limited older men despite improvement in physical function.尽管体力功能得到改善,但睾酮并不能影响活动受限的老年男性中聚集蛋白聚糖的裂解。
Andrology. 2018 Jan;6(1):29-36. doi: 10.1111/andr.12424. Epub 2017 Sep 26.
7
Biomarkers of sarcopenia in very old patients with hip fracture.高龄髋部骨折患者肌肉减少症的生物标志物
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):478-486. doi: 10.1002/jcsm.12508. Epub 2020 Jan 8.
8
Plasma C-terminal agrin fragment concentrations across adulthood: Reference values and associations with skeletal muscle health.成年期血浆C末端聚集蛋白片段浓度:参考值及其与骨骼肌健康的关联。
J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1501-1510. doi: 10.1002/jcsm.13507. Epub 2024 Jun 7.
9
Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).使用 C 端 agrin 片段检测慢性心力衰竭患者的肌肉减少症:来自研究共病加重心力衰竭(SICA-HF)的结果。
Eur J Heart Fail. 2015 Dec;17(12):1283-93. doi: 10.1002/ejhf.400. Epub 2015 Oct 9.
10
C-terminal agrin fragment is inversely related to neuromuscular fatigue in older men.C 端聚集蛋白片段与老年男性的神经肌肉疲劳呈负相关。
Muscle Nerve. 2015 Jan;51(1):132-3. doi: 10.1002/mus.24443. Epub 2014 Nov 24.

引用本文的文献

1
Pathophysiological Mechanisms Underlying Sarcopenia and Sarcopenic Obesity: A Systematic Review and Meta-Analysis of Biomarker Evidence.肌肉减少症和肌肉减少性肥胖的病理生理机制:生物标志物证据的系统评价和荟萃分析
Int J Mol Sci. 2025 May 26;26(11):5113. doi: 10.3390/ijms26115113.
2
Serum C-Terminal Agrin Fragment With Acute and Long-Term Exercise and Angiotensin II Type I Receptor Blockade.血清C端聚集蛋白聚糖片段与急性和长期运动及血管紧张素II 1型受体阻断
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13832. doi: 10.1002/jcsm.13832.
3
Effect of Reablement Strategies targeting Sarcopenia (ReStart-S) on sarcopenic older adults residing in long term care settings: A protocol for cluster randomized trial.
针对肌肉减少症的康复策略(ReStart-S)对长期护理机构中患有肌肉减少症的老年人的影响:一项整群随机试验方案
Heliyon. 2025 Jan 24;11(3):e42174. doi: 10.1016/j.heliyon.2025.e42174. eCollection 2025 Feb 15.
4
C-Terminal Agrin Fragment as a Biomarker for Sarcopenia: A Systematic Review and Meta-Analysis.C 末端聚集蛋白片段作为肌肉减少症的生物标志物:一项系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13707. doi: 10.1002/jcsm.13707.
5
Systematic Review of Sarcopenia Biomarkers in Hip Fracture Patients as a Potential Tool in Clinical Evaluation.髋部骨折患者肌少症生物标志物的系统评价:临床评估的潜在工具
Int J Mol Sci. 2024 Dec 15;25(24):13433. doi: 10.3390/ijms252413433.
6
Acetylcholine receptor-β inhibition by interleukin-6 in skeletal muscles contributes to modulating neuromuscular junction during aging.白细胞介素-6 在骨骼肌中对乙酰胆碱受体-β的抑制作用有助于调节衰老过程中的神经肌肉接头。
Mol Med. 2024 Oct 10;30(1):171. doi: 10.1186/s10020-024-00943-3.
7
Plasma C-terminal agrin fragment concentrations across adulthood: Reference values and associations with skeletal muscle health.成年期血浆C末端聚集蛋白片段浓度:参考值及其与骨骼肌健康的关联。
J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1501-1510. doi: 10.1002/jcsm.13507. Epub 2024 Jun 7.
8
Effect of targeted intervention on C-terminal agrin fragment and its association with the components of sarcopenia: a scoping review.靶向干预对 C 端聚集蛋白片段及其与肌少症成分相关性的影响:范围综述。
Aging Clin Exp Res. 2023 Jun;35(6):1161-1186. doi: 10.1007/s40520-023-02396-w. Epub 2023 Mar 28.
9
C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review.C 端神经胶质细胞源性神经营养因子片段作为肌肉减少症和肌肉无力的生物标志物:叙事性综述。
J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):730-744. doi: 10.1002/jcsm.13189. Epub 2023 Feb 11.
10
Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.用于评估旨在治疗肌少症药物临床试验的肌肉骨骼健康和衰老的生物化学标志物:欧洲临床和经济骨质疏松症、骨关节炎和肌肉骨骼疾病学会(ESCEO)和学术研究与健康实验中心(CARES SPRL)专家组会议的共识文件,由世界卫生组织骨骼肌肉疾病和老龄化流行病学合作中心主办。
Calcif Tissue Int. 2023 Feb;112(2):197-217. doi: 10.1007/s00223-022-01054-z. Epub 2023 Jan 12.